ID: ALA4089599

Max Phase: Preclinical

Molecular Formula: C26H38N3NaO9S

Molecular Weight: 569.68

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCCC(=O)OC([C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)S(=O)(=O)[O-].[Na+]

Standard InChI:  InChI=1S/C26H39N3O9S.Na/c1-4-5-11-22(30)38-25(39(34,35)36)21(15-19-12-13-27-23(19)31)28-24(32)20(14-17(2)3)29-26(33)37-16-18-9-7-6-8-10-18;/h6-10,17,19-21,25H,4-5,11-16H2,1-3H3,(H,27,31)(H,28,32)(H,29,33)(H,34,35,36);/q;+1/p-1/t19-,20-,21-,25?;/m0./s1

Standard InChI Key:  SOEHNWOLPGPYPD-KNNWGLAJSA-M

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 569.68

Molecular Weight (Monoisotopic): 569.2407

AlogP: 2.29

#Rotatable Bonds: 15

Polar Surface Area: 177.20

Molecular Species: ACID

HBA: 8

HBD: 4

#RO5 Violations: 1

HBA (Lipinski): 12

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 2

CX Acidic pKa: -0.80

CX Basic pKa:

CX LogP: 1.58

CX LogD: 0.19

Aromatic Rings: 1

Heavy Atoms: 39

QED Weighted: 0.18

Np Likeness Score: 0.24

References

1. Galasiti Kankanamalage AC, Kim Y, Rathnayake AD, Alliston KR, Butler MM, Cardinale SC, Bowlin TL, Groutas WC, Chang KO..  (2017)  Design, Synthesis, and Evaluation of Novel Prodrugs of Transition State Inhibitors of Norovirus 3CL Protease.,  60  (14): [PMID:28671827] [10.1021/acs.jmedchem.7b00497]

Source

Source(1):

• Scientific Literature